Prognostic implications of risk definitions from the monarchE and NATALEE trials.
AuteursArecco L, Blondeaux E, Bruzzone M, Arpino G, De Angelis C, De Laurentiis M, Caputo R, Fabi A, Sanna V, Gori S, Puglisi F, Boni L, Nardin S, Giannubilo I, Perachino M, Borea R, Agostinetto E, de Azambuja E, Lambertini M, Del Mastro L
A transcriptomic score to classify the inflammation-dysplasia-cancer sequence lesions in Inflammatory Bowel Disease.
AuteursCremer A, Rosewick N, Kelsey M, Trépo E, Libert F, De Vos M, Baert F, Moreels T, Louis E, Rahier JF, Demetter P, Sedivy JM, Vermeire S, Franchimont D
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer.
AuteursBonaca MP, Lang NN, Chen A, Amiri-Kordestani L, Lipka L, Zwiewka M, Strnadova C, Klaar S, Dent S, Janicijevic TK, Herrmann J, Barac A, de Boer RA, Deswal A, Schou M, Neilan TG, van der Meer P, Moslehi J, Kondapalli L, Ky B, Fernandez TL, Cornell RF, Flaig TW, Hsia J, Sharon E, de Azambuja E, Seltzer J, Januzzi JL, Petrie MC
Are Patients with Prostate Imaging Reporting and Data System 5 Lesions Eligible for Active Surveillance? A Multicentric European Study.
AuteursPeyrottes A, Baboudjian M, Diamand R, Ducrot Q, Vitard C, Baudewyns A, Windisch O, Anract J, Dariane C, Tricard T, Sarkis J, Sadreux Y, Oderda M, Depaquit TL, La Taille A, Olivier J, Brureau L, Rouviere O, Crouzet S, Ruffion A, Desgrandchamps F, Roumiguie M, Rouprêt M, Ploussard G, Fiard G
Morphology of Retinal Hemangioblastoma in von Hippel-Lindau Disease Revealed by Optical Coherence Tomography Angiography.
AuteursLaich Y, Lang SJ, Glatz A, Farassat N, Bucher F, Nuessle S, Böhringer D, Lagrèze WA, Sideris S, Maloca P, Lange C, Reinhard T, Agostini H, Reich M
